Literature DB >> 24736759

Acute coronary syndromes: Aleglitazar trial findings reported.

Bryony M Mearns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24736759     DOI： 10.1038/nrcardio.2014.53

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.

Authors:  A Michael Lincoff; Jean-Claude Tardif; Gregory G Schwartz; Stephen J Nicholls; Lars Rydén; Bruce Neal; Klas Malmberg; Hans Wedel; John B Buse; Robert R Henry; Arlette Weichert; Ruth Cannata; Anders Svensson; Dietmar Volz; Diederick E Grobbee
Journal:  JAMA       Date:  2014-04-16       Impact factor: 56.272
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.